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Necrotizing fasciitis (NF) is a life-threatening, rare soft tissue infection characterized by rapidly spreading
necrosis of the fascia and subcutaneous tissue, muscle, and overlying skin. Once suspected, immediate
and extensive surgical debridement of necrotic tissues and appropriate systemic antibiotic coverage are
necessary. On the contrary, pyoderma gangrenosum (PG) is an auto-inﬂammatory condition of the skin
that has been associated with multiple factors including inﬂammatory bowel disease, arthritis, and
myelodysplastic disorders. It is a non-infectious process requiring non-surgical management. Both
conditions are rare in the pediatric population, and may present with signiﬁcant ulceration and tissue
necrosis. Lack of diagnostic clinical, histopathologic, and laboratory features make identiﬁcation of these
entities challenging. We present a case of pyoderma gangrenosum, initially diagnosed as cellulitis and
necrotizing fasciitis, to highlight the diagnostic challenges involved in differentiating these disease en-
tities and clinical implications of misdiagnosis or delayed diagnosis.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license. Pyoderma gangrenosum (PG) is an inﬂammatory dermatologic
condition that presents with ulceration and tissue necrosis, similar
to infectious processes including necrotizing fasciitis (NF) [1,2]. Our
case report highlights the diagnostic pitfalls and associated clinical
implications of these disease entities and emphasizes the signiﬁ-
cance of understanding the pathogenesis, clinical features, and
management of both conditions.
1. Case report
A 16-year-old female was transferred to the University of Florida
(UF) hospital with a working diagnosis of necrotizing fasciitis. A
brief history of her presentation indicated that she had been bitten
by a cat on her left hand 2 weeks prior and was seen by her primary
care doctor who administered an intramuscular injection of cef-
triaxone on the right gluteal region. Within 2 days, she developed
erythema, intense pain, and vesiculation at the injection site. She
went to the local emergency departmentwhere shewas found to be
febrile with a temperature of 104F with signiﬁcant leukocytosis e
white blood cell count of 30,000/mm3, and elevated inﬂammatory
markers e C-reactive protein (CRP) of 300 mg/L. A diagnosis of
cellulitis was made (Fig. 1), cultures obtained and systemicþ1 352 5941926.
(M.W. Wangia).
-NC-ND license. antibiotics initiated with zosyn (piperacillin and tazobactam) and
vancomycin. A surgery consultation was initiated for debridement
of necrotic wound areas. One day following debridement, exag-
geration of the ulceratedmargins was noted and diagnosis modiﬁed
to necrotizing fasciitis. Her hospitalization was complicated by
systemic inﬂammatory response syndrome (SIRS), lobar pneu-
monia and septic shock requiring ﬂuid resuscitation and vaso-
pressors. She also had a left upper extremity deep venous
thrombosis and ulceration at the site of a peripherally inserted
central catheter, necessitating anticoagulation therapy. A decision
was made to transfer the patient to UF hospital for hyperbaric ox-
ygen therapy.
The patient was admitted to our pediatric intensive care unit
where her wounds were managed by hyperbaric oxygen treat-
ments, serial surgical debridement of necrotic tissue, systemic an-
tibiotics, and negative pressure wound therapy using a vacuum
assisted closure dressing. She still had intermittent fevers and her
inﬂammatory markers and leukocytosis remained elevated. Surgi-
cal debridement resulted in remarkable expansion of wound mar-
gins (Fig. 2). All blood, urine, sputum, and tissue cultures were
negative. Tissue samples sent for histopathologic diagnosis
revealed erosion of the epidermis with dense and diffuse neutro-
philic inﬁltrate in the dermis and subcutis were thought to be
suggestive of an acute cellulitis and panniculitis compatible with
necrotizing fasciitis (Fig. 3). Special stains for bacteria, fungi, and
Fig. 1. Cellulitis with focal areas of bullae formation.
Fig. 3. Nodular and diffuse neutrophilic inﬁltration of the dermis and subcutis.
M.W. Wangia et al. / J Ped Surg Case Reports 1 (2013) 139e142140spirochetes including gram, periodic acid-schiff, and steiner stains
respectively, were performed and were all negative. Dermatology
service was consulted 1 week into her hospitalization given lack of
clinical improvement despite current therapies. Further querying of
the patient’s mother revealed a personal history of gastrointensinal
(GI) symptoms including nausea without emesis, abdominal pain,
and occasional diarrhea without mention of melena or hema-
tochezia during the preceding year. She had no family history of
inﬂammatory bowel disease, hematologic disease or autoimmune
disease.
Based on the history of pathergy (skin lesions at sites of trauma),
clinical ﬁndings, laboratory ﬁndings, histopathology, and multiple
negative microbiology studies, the dermatology service favored a
diagnosis of pyoderma gangrenosum. Recommendations for ther-
apy included discontinuation of further surgical manipulation
including avoidance of grafting, and initiation of systemic cortico-
steroids at 1e2 mg/kg/day. The primary team was also advised to
consider further gastrointestinal and hematologic evaluation to
assess for a possible underlying etiology of PG. Gradual improve-
ment of her wounds was noted within three days after initiation of
therapy helping to further support a diagnosis of PG. Remarkable
improvement was noted at week 7 during an outpatient visitFig. 2. Extensive deep ulceration from right buttock to ﬂank with exposed subcu-
taneous fat, fascia, and muscle. Status post serial surgical debridements.(Fig. 4), as well as normalization of her leukocyte count and in-
ﬂammatory markers.
2. Discussion
Pyoderma gangrenosum (PG) is an inﬂammatory condition of
the skin ﬁrst described by Brunsting and colleagues in 1930 [1]. The
etiopathogenesis of PG is unknown, but studies have suggested that
the primary process may arise from abnormal neutrophil chemo-
taxis as well as impaired phagocytosis and oxygen uptake [2,3]. PG
is a neutrophilic dermatosis characterized by recurrent ulcerations
or erosions with a peak incidence between ages of 20 and 50 years.
There are rare cases of affected children, which comprise 4% of
reported cases [4]. Elderly patients are rarely affected and women
seem to have higher incidence than men. PG is often associated
with systemic disease in about 50% of reported cases, most
commonly inﬂammatory bowel disease (IBD), arthritis, and he-
matologic disease including acute myeloid and lymphoid leukemia,
andmonoclonal gammopathy. PG has been described in association
with other autoimmune diseases, infections such as the human
immunodeﬁciency virus (HIV), Hodgkin and non-Hodgkin lym-
phoma and solid tumors [3,5].
Evolution of PG begins as a pustule or vesicopustule that pro-
gresses to frank ulceration or deep erosion with violaceousFig. 4. Signiﬁcant improvement in ulceration at week 7 of systemic corticosteroid
therapy.
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clinically distinct variations. Classic PG, characterized by ulcers
usually located on lower extremities in adults whereas in the pe-
diatric population, the buttocks, perineum and head, and neck are
most commonly affected; atypical PG characterized by more su-
perﬁcial ulcers or deep erosions with a blue-gray, bullous border
found on the hands, arms or face; and peristomal PG, deﬁned by the
occurrence of lesions around a stoma, usually following surgery [6].
Prototypic classiﬁcation of PG includes ulcerative, pustular, bullous,
and vegetative types. The course of PG can be acute, relapsing, or
chronic. Relapsing or chronic courses are more apt to be associated
with an underlying disease process [5,6]. Cutaneous pathergy is
an important clinical feature of PG, and is marked by the develop-
ment of skin lesions as sites of injury [6]. In our patient, ulceration
and necrosis developing at the initial site of the gluteal injection,
and subsequent ulcers emanating from peripherally inserted cen-
tral catheter on left upper extremity, coupled with steady
enlargement of woundswith each debridement, are all hallmarks of
the pathergy phenomenon. Extracutaneous disease is rare, but af-
fects lung (pulmonary inﬁltrates), bone (“multifocal sterile recur-
rent osteomyelitis”), and joints (pyoarthrosis). The heart, central
nervous system, cornea, liver, spleen, and oropharynx may be
involved [6].
Pyoderma gangrenosum is a diagnosis of exclusion and involves
elimination of other diseases that cause ulcerative, necrotic or
erosive cutaneous lesions [1e7]. The absence of diagnostic labora-
tory or histopathologic features results in misdiagnosis of PG,
estimated at approximately 10% in a retrospective study byWeenig
et al. Misdiagnosis exposes patients to risks associated with treat-
ment as seen in our patient. Differential diagnosis of PG includes
primary infection such as necrotizing fasciitis, vascular occlusive or
venous disease, necrotizing vasculitis, malignant process involving
skin and drug-induced or exogenous tissue injury [6,7].
Management of PG depends on severity of the disease and can
involve local wound care and topical therapy to use of systemic
therapies. Immunosuppressive therapy includes systemic cortico-
steroids, and steroid sparing agents including tumor necrosis factor
inhibitors such as inﬂiximab, azathioprine, cysclopsorine, tacroli-
mus, mycophenolate mofetil, chlorambucil, thalidomide, and other
systemic agents [6,7].
In review of the literature, misdiagnosis of PG and treatment as
necrotizing fasciitis is not uncommon [3,7e9].
Necrotizing fasciitis (NF) is a severe life-threatening soft tissue
infection characterized by rapidly spreading necrosis of the fascia,
subcutaneous tissue, muscle and overlying skin [9,10]. It is a rare
infectious entity that presents diagnostic and therapeutic chal-
lenges for the pediatric surgeon. It has been reported in 0.08/
100,000 children/year. Its incidence however, has been increasing
in recent years due to invasive Streptococcus pyogenes. Initiating
factors include minor and major trauma as observed in our patient,
surgical wounds and varicella lesions. The most common site of
initial involvement in adults is the lower extremity, however, in the
pediatric population; it is the abdominal wall, followed by the
gluteal region and thigh, head and neck, and upper and lower ex-
tremities. Initial skin presentation includes induration or cellulitis
with progression to skin discoloration, and bullae formation as
observed in our patient. Exquisite pain out of proportion with skin
ﬁndings, leukocytosis, elevated creatinine kinase, fever, and
tachycardia are important associated clinical ﬁndings. Presence of
ulceration, ecchymosis, crepitus, anesthesia, and necrosis are
indicative of an advanced disease process [10]. In a study by Bingol-
Kologlu et al., S. pyogeneswas the most common causative agent in
children followed by Staphylococcus epidermidis, Pseudomonas aer-
uginosa, Escherichia coli, and vibrio species. In contrast to adults, NF
is usually a monomicrobial infection in children [10].NF is common in immunosuppressed and diabetic adult pa-
tients. However, it can also affect previously healthy children [11].
Once a diagnosis of NF is suspected, intensive care, early and
aggressive surgical debridement followed by appropriate antibi-
otics is warranted [7e11]. In one large published series, diagnosis of
NF was missed in 85e100% of reviewed cases due to the paucity of
cutaneous ﬁndings early in the course of the disease process [11].
NF is a fulminant infective process, which can result in signiﬁcant
morbidity and mortality. Delayed diagnosis results in a mortality
rate of approximately 25e40% [12].
A high index of suspicion is required in the diagnosis of PG or
NF. Ulceration, tissue necrosis, and deep erosions are clinical fea-
tures that can be manifested in both conditions. There is no
microscopic pattern that is diagnostic of PG or NF, however, PG
usually presents with a predominantly neutrophilic inﬁltration
whereas necrotizing fasciitis has a mixed lymphohistiocytic and
neutrophilic inﬁltrate with suppuration, edema and necrosis of
superﬁcial fascia and blood vessel thrombosis in advanced lesions
[12]. These ﬁndings may be variable depending on biopsy site and
the stage of evolution of the lesion. The rapidity of induration and
tissue necrosis in hours rather than days may help in deﬁning NF. A
positive tissue culture or staining aids in diagnosis of NF, but
cannot rule out a secondarily infected PG lesion. Cutaneous
pathergy is observed in cases of PG but not in NF. In our case, the
lack of clinical improvement with aggressive surgical debridement
and systemic antibiotics, multiple negative tissue cultures and
stains, histopathologic evidence of neutrophilic inﬁltration in the
dermis and subcutis, evidence of pathergy and eventual improve-
ment with immunosuppression helped in establishing the elusive
diagnosis of pyoderma gangrenosum over what was presumed to
be necrotizing fasciitis. Our patient still requires further evaluation
of her GI symptoms and long-term follow up to rule out an un-
derlying disease process. Aggressive management of PG with sys-
temic antibiotics and extensive surgical debridement can result
in large tissue defects with challenging reconstructive implications
and psychosocial repercussions. On the contrary, treatment of
NF with immunosuppressive therapy may result in signiﬁcant
morbidity and mortality.
3. Conclusion
This case highlights the signiﬁcance of understanding the etio-
pathogenesis, clinical features, and clinicalepathologic correlation
in the management of both pyoderma gangrenosum and necro-
tizing fasciitis. It also illuminates the importance of reconsidering a
preliminary diagnosis when a disease process is not responsive to
instituted therapy.
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